239 related articles for article (PubMed ID: 3089917)
1. C3 activation by a new factor B-dependent enzyme detected in culture supernatant from guinea-pig peritoneal macrophages.
Beuscher HU; Brade V
Immunology; 1986 Aug; 58(4):545-51. PubMed ID: 3089917
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
Sturtevant JE; Balber AE
Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
[TBL] [Abstract][Full Text] [Related]
4. The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.
DiScipio RG
Biochem J; 1981 Dec; 199(3):497-504. PubMed ID: 6918218
[TBL] [Abstract][Full Text] [Related]
5. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cleavage of the third component of human complement (C3) by its small cleavage fragment, C3a: inhibition occurs with the classical-pathway, but not the alternative-pathway, C3 convertase.
Strunk RC; Webster RO
Mol Immunol; 1985 Jan; 22(1):37-43. PubMed ID: 3871899
[TBL] [Abstract][Full Text] [Related]
7. The C3/C5 convertase of the alternative pathway of complement: stabilization and restriction of control by lanthanide ions.
Fishelson Z; Müller-Eberhard HJ
Mol Immunol; 1983 Mar; 20(3):309-15. PubMed ID: 6553181
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.
Bentley C; Fries W; Brade V
Immunology; 1978 Dec; 35(6):971-80. PubMed ID: 104925
[TBL] [Abstract][Full Text] [Related]
9. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
10. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
11. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.
Pangburn MK; Müller-Eberhard HJ
Biochem J; 1986 May; 235(3):723-30. PubMed ID: 3638964
[TBL] [Abstract][Full Text] [Related]
12. Functional active complement components secreted by guinea pig peritoneal macrophages.
Brade V; Kreuzpaintner G
Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the initial C3 convertase of the alternative pathway of human complement.
Fishelson Z; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1430-4. PubMed ID: 6559201
[TBL] [Abstract][Full Text] [Related]
14. The activation of the alternative pathway C3 convertase by human plasma kallikrein.
DiScipio RG
Immunology; 1982 Mar; 45(3):587-95. PubMed ID: 6916710
[TBL] [Abstract][Full Text] [Related]
15. A reexamination of the role of magnesium in the human alternative pathway of complement.
Pryzdial EL; Isenman DE
Mol Immunol; 1986 Jan; 23(1):87-96. PubMed ID: 3634188
[TBL] [Abstract][Full Text] [Related]
16. Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies.
Burger R; Deubel U; Hadding U; Bitter-Suermann D
J Immunol; 1982 Nov; 129(5):2042-50. PubMed ID: 6181157
[No Abstract] [Full Text] [Related]
17. Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation.
Vogt W; Schmidt G; Hinsch B
Immunology; 1979 Jan; 36(1):139-43. PubMed ID: 422225
[TBL] [Abstract][Full Text] [Related]
18. Effect of cycloheximide and of anti-C3 Fab' on the intrinsic synthesis and secretion of lysosomal enzyme and of complement components by guinea-pig peritoneal macrophages.
Kreuzpaintner G; Brade V
Immunology; 1983 Jun; 49(2):337-42. PubMed ID: 6552217
[TBL] [Abstract][Full Text] [Related]
19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
20. The activation of the C3b feedback cycle with human complement components. I. Through the classical pathway.
Mak LW; Lachmann PJ; Majewski J
Clin Exp Immunol; 1977 Nov; 30(2):200-10. PubMed ID: 606442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
